These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Recognizing and treating malignant hyperthermia. Corvetto MA; Taekman JM Simul Healthc; 2010 Jun; 5(3):169-72. PubMed ID: 20651479 [No Abstract] [Full Text] [Related]
25. Malignant hyperthermia: responses of skeletal muscles to general anesthetics. Gallant EM; Ahern CP Mayo Clin Proc; 1983 Nov; 58(11):758-63. PubMed ID: 6355673 [TBL] [Abstract][Full Text] [Related]
26. Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia. Dexter F; Epstein RH; Wachtel RE; Rosenberg H Anesth Analg; 2013 Jan; 116(1):118-22. PubMed ID: 23223104 [TBL] [Abstract][Full Text] [Related]
27. Malignant hyperthermia. Ali SZ; Taguchi A; Rosenberg H Best Pract Res Clin Anaesthesiol; 2003 Dec; 17(4):519-33. PubMed ID: 14661655 [TBL] [Abstract][Full Text] [Related]
28. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine. Harrison GG Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645 [TBL] [Abstract][Full Text] [Related]
29. [Reasons for the persistent lethality of malignant hyperthermia and recommendations for its reduction]. Schulte-Sasse U; Eberlein HJ Anaesthesiol Reanim; 1991; 16(3):202-7. PubMed ID: 1888426 [TBL] [Abstract][Full Text] [Related]
30. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle. Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479 [TBL] [Abstract][Full Text] [Related]
31. Dantrolene in human malignant hyperthermia. Kolb ME; Horne ML; Martz R Anesthesiology; 1982 Apr; 56(4):254-62. PubMed ID: 7039419 [TBL] [Abstract][Full Text] [Related]
32. Dantrolene for malignant hyperthermia during anesthesia. Med Lett Drugs Ther; 1980 Jul; 22(15):61-2. PubMed ID: 7393124 [No Abstract] [Full Text] [Related]
33. Malignant hyperthermia: a potentially fatal complication of anesthesia. Stolworthy C; Haas RE Semin Perioper Nurs; 1998 Jan; 7(1):58-66. PubMed ID: 9510843 [TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis of stocking dantrolene in ambulatory surgery centers for the treatment of malignant hyperthermia. Aderibigbe T; Lang BH; Rosenberg H; Chen Q; Li G Anesthesiology; 2014 Jun; 120(6):1333-8. PubMed ID: 24714119 [TBL] [Abstract][Full Text] [Related]
35. Human malignant hyperthermia associated with desflurane anesthesia. Allen GC; Brubaker CL Anesth Analg; 1998 Jun; 86(6):1328-31. PubMed ID: 9620529 [No Abstract] [Full Text] [Related]
36. Delayed onset of malignant hyperthermia in desflurane anesthesia. Hoenemann CW; Halene-Holtgraeve TB; Booke M; Hinder F; Daudel F; Reich A; Van Aken H Anesth Analg; 2003 Jan; 96(1):165-7, table of contents. PubMed ID: 12505945 [TBL] [Abstract][Full Text] [Related]